GC Genome Corp

GC Genome Corp is a South Korean biotechnology company specializing in clinical genome analysis and advanced genetic testing services. Founded in 2013 and headquartered in Yongin, South Korea, the company serves a broad spectrum of healthcare needs by offering over 300 types of genetic tests. Its core areas include prenatal and newborn screening, health checkups for healthy individuals, cancer precision diagnostics, and the diagnosis of rare genetic diseases. Leveraging cutting-edge technologies such as next-generation sequencing (NGS) and artificial intelligence, GC Genome provides solutions for disease detection, risk screening, and the realization of personalized medicine. The company is recognized for proprietary platforms like Genome Health, a SNP genotyping service for multi-disease risk assessment, as well as AI-driven liquid biopsy tests for multi-cancer screening. GC Genome actively collaborates in international markets and invests heavily in R&D to develop innovative diagnostic methodologies, participating in national and global research initiatives. As part of the GC Biopharma group, GC Genome plays a pivotal role in South Korea’s precision medicine landscape, aiming to advance human health through early detection, tailored treatment, and genomic-driven insights.